Related News

April 3, 2020

SmarTrend identified a Downtrend for Intra-Cellular T (NASDAQ:ITCI) on January 8th, 2020 at $27.19. In approximately 3 months, Intra-Cellular T has returned 47.08% as of today's recent price of $14.39.

In...

March 30, 2020

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.

Prestige...

March 27, 2020

Below are the three companies in the Pharmaceuticals industry with the highest betas. Higher-beta stocks mean greater volatility and are therefore generally considered to be riskier but also may provide the potential for higher returns.

...

March 27, 2020

SmarTrend identified a Downtrend for Intra-Cellular T (NASDAQ:ITCI) on January 8th, 2020 at $27.19. In approximately 3 months, Intra-Cellular T has returned 44.43% as of today's recent price of $15.11.

In...

March 25, 2020

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at yesterday's price action of all companies...

March 9, 2020

SmarTrend identified a Downtrend for Intra-Cellular T (NASDAQ:ITCI) on January 8th, 2020 at $27.19. In approximately 2 months, Intra-Cellular T has returned 22.36% as of today's recent price of $21.11.

...

March 6, 2020

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at yesterday's price action of all companies...

March 2, 2020

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at yesterday's price action of all companies...

February 28, 2020

Below are the three companies in the Pharmaceuticals industry with the highest betas. Higher-beta stocks mean greater volatility and are therefore generally considered to be riskier but also may provide the potential for higher returns.

...

February 20, 2020

SmarTrend identified a Downtrend for Intra-Cellular T (NASDAQ:ITCI) on January 8th, 2020 at $27.19. In approximately 1 month, Intra-Cellular T has returned 7.54% as of today's recent price of $25.14.

In the...